Bots, editor, reviewer, Administrators
13,951
edits
Feed:All articles/Pretty: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 2,414: | Line 2,414: | ||
"title" : "Closure of patent foramen ovale versus medical therapy after cryptogenic stroke", | "title" : "Closure of patent foramen ovale versus medical therapy after cryptogenic stroke", | ||
"pmid" : "23514286" | "pmid" : "23514286" | ||
}, | |||
{ | |||
"timestamp" : "2014-05-14T09:39:22Z", | |||
"briefDesignDescription" : "Rifaximin/lactulose vs. lactulose for acute HE", | |||
"fulltexturl" : "http://www.nature.com/ajg/journal/v108/n9/full/ajg2013219a.html", | |||
"pageid" : 1784, | |||
"pdfurl" : "http://www.nature.com/ajg/journal/v108/n9/pdf/ajg2013219a.pdf", | |||
"trainingLevel" : "Intern", | |||
"citation" : "Sharma BC, <i>et al</i>. \"A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy\". <i>The American Journal of Gastroenterology</i>. 2013. 108(9):1458-1463.", | |||
"subspecialties" : "Gastroenterology", | |||
"expansion" : "", | |||
"briefResultsDescription" : "Rifaximin/lactulose improved rates of HE reversal and survival, reduced hospital LOS", | |||
"published" : "2013-09-01", | |||
"pageName" : "Rifaximin and Lactulose for HE", | |||
"diseases" : "Hepatic Encephalopathy", | |||
"abbreviation" : "", | |||
"title" : "A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy", | |||
"pmid" : "23877348" | |||
}, | }, | ||
{ | { | ||
| Line 2,810: | Line 2,828: | ||
"title" : "Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes", | "title" : "Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes", | ||
"pmid" : "17982182" | "pmid" : "17982182" | ||
}, | |||
{ | |||
"timestamp" : "2014-05-14T09:24:59Z", | |||
"briefDesignDescription" : "33 vs. 36°C hypothermia after cardiac arrest", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1310519", | |||
"pageid" : 1783, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1310519", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Nielsen N, <i>et al</i>. \"Target Temperature Management 33°C vs. 36°C after Out-of Hospital Cardiac Arrest\". <i>The New England Journal of Medicine</i>. 2013. 369(23):2197-2206.", | |||
"subspecialties" : "Cardiology;Neurology;Critical Care", | |||
"expansion" : "arget Temperature Management 33°C vs. 36°C after Out-of Hospital Cardiac Arrest", | |||
"briefResultsDescription" : "33°C cooling provides no survival benefit over 36°C", | |||
"published" : "2014-03-19", | |||
"pageName" : "TTM", | |||
"diseases" : "Cardiac Arrest", | |||
"abbreviation" : "TTM", | |||
"title" : "Target Temperature Management 33°C vs. 36°C after Out-of Hospital Cardiac Arrest", | |||
"pmid" : "24237006" | |||
}, | }, | ||
{ | { | ||